Banyan Partners, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 86 filers reported holding IMMUNOMEDICS INC in Q4 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
Banyan Partners, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2014$725,000
+1.8%
195,0000.0%0.06%
+3.3%
Q2 2014$712,000
-13.3%
195,0000.0%0.06%
-15.5%
Q1 2014$821,000
-8.5%
195,0000.0%0.07%
+12.7%
Q4 2013$897,000
-17.3%
195,000
+11.4%
0.06%
-34.4%
Q3 2013$1,085,000
+14.0%
175,0000.0%0.10%
-48.7%
Q2 2013$952,000175,0000.19%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 4,750,000$112,433,00020.02%
Avoro Capital Advisors LLC 17,714,461$419,301,00016.14%
Foresite Capital Management III, LLC 2,541,729$60,163,00012.96%
Foresite Capital Management IV, LLC 1,231,543$29,151,0009.94%
Ghost Tree Capital, LLC 1,250,000$29,588,0008.71%
NEXTHERA CAPITAL LP 1,329,104$31,460,0004.87%
RA Capital Management 3,119,778$73,845,0004.79%
DLD Asset Management, LP 2,682,100$63,458,0004.78%
Palo Alto Investors LP 4,803,364$113,696,0004.54%
DLD Asset Management, LP 2,411,600$57,058,0004.30%
View complete list of IMMUNOMEDICS INC shareholders